← Open Payments lookup

MISTIE KOCUREK: Open Payments

NPI 1629520184 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$557 in 24 payments from 15 companies in 2025. Trend: 2023 $258 · 2024 $342 · 2025 $557

Food & beverage: $557
CompanyPaymentsAmount
Novo Nordisk Inc5$239
ABBVIE INC.2$48
Corcept Therapeutics2$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Axsome Therapeutics, Inc.1$27
Sumitomo Pharma America, Inc.1$25
Exeltis, USA Inc.1$24
Lilly USA, LLC1$20
Otsuka America Pharmaceutical, Inc.1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$18

Products named: Wegovy, Ozempic, Korlym, REXULTI, QULIPTA, XIFAXAN, Symbravo, GEMTESA.

Industry payments across TX — which companies pay providers there.